Study led by Manitoba doctor shows promising treatment for COVID-19 patients
A global trial led by Winnipeg and Canadian researchers is showing promising results in treating some COVID-19 cases.
Dr. Ryan Zarychanski’s study on blood thinners in COVID positive patients was published Wednesday in the New England Journal of Medicine.
The study found that treating some hospitalized patients with blood thinners increases their chance of survival and reduces their need for intensive care.
"A blood thinner drug that has anti-inflammatory and antiviral properties has been shown in our large global trial to increase survival without the need for ICU-level care," said Zarychanski.
That drug is heparin, an inexpensive and widely available medication used to treat blood clots. Blood clots and inflammation were noted early on in the pandemic as serious complications of COVID-19.
“For us to demonstrate that a drug that is incredibly inexpensive, widely available around the world and familiar to doctors all over the globe, for us to demonstrate that this drug could be used too, and can save lives and reduce the burden of critical illness on health-care systems is a huge win,” said Zarychanski.
The findings could impact patient care immediately, with Zarychanski saying physicians within organized health-care systems could start using heparin molecules to treat patients admitted to hospital with the virus, but who are not yet critically ill.
"We think it will reduce the burden of critical illness due to COVID-19 by approximately 25 per cent when used in health systems that adopt that therapy," said Zarychanski.
While results in December of 2020 showed no benefits to those already critically ill, the researchers say it could be a key tool in saving the lives of non-critically ill patients by knowing who to target.
The study was also the first of its kind, a clinical trial on a global scale during a pandemic. Zarychanski said the methods developed during the study will change how researchers approach large-scale clinical trials in the future.
“We developed methods that allowed independent platforms, so independent research entities can still maintain their independence but work collaboratively,” said Zarychanski.
The trial spanned five continents and involved patients from 300 hospitals.
CTVNews.ca Top Stories
'A beautiful soul': Funeral held for baby boy killed in wrong-way crash on Highway 401
A funeral was held on Wednesday for a three-month-old boy who died after being involved in a wrong-way crash on Highway 401 in Whitby last week.
Police handcuff man trying to enter Drake's Toronto mansion
Toronto police say a man was taken into custody outside Drake's Bridle Path mansion Wednesday afternoon after he tried to gain access to the residence.
Biden says he will stop sending bombs and artillery shells to Israel if they launch major invasion of Rafah
U.S. President Joe Biden said for the first time Wednesday he would halt shipments of American weapons to Israel, which he acknowledged have been used to kill civilians in Gaza, if Prime Minister Benjamin Netanyahu orders a major invasion of the city of Rafah.
U.S. presidential candidate RFK Jr. had a brain worm, has recovered, campaign says
Independent U.S. presidential candidate Robert F. Kennedy Jr. had a parasite in his brain more than a decade ago, but has fully recovered, his campaign said, after the New York Times reported about the ailment.
Ontario Provincial Police arrest 64 suspects in child sexual exploitation investigation
Ontario Provincial Police say 64 suspects are facing a combined 348 charges in connection with a series of child sexual exploitation investigations that spanned the province.
Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg News
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Quebec premier defends new museum on Quebecois nation after Indigenous criticism
Quebec Premier Francois Legault is defending his comments about a new history museum after he was accused by a prominent First Nations group of trying to erase their history.
Blind Sask. boy heading to international braille competition hopes to increase accessibility for visually impaired
A Saskatchewan boy who qualified for an international braille competition in Los Angeles next month hopes he can inspire change in his home province.
'A step forward': New screening criteria for sperm donors takes effect
Canadians looking to grow their families with the assistance of sperm or egg donations should soon have more options for donors as the federal health agency does away with longstanding restrictions criticized as discriminatory.